Stepladder technique successful for malignant glaucoma

Article

Malignant glaucoma can be successfully managed using the stepladder technique, including timely and appropriate interventions, claims a paper in the journal Ophthalmology.

Malignant glaucoma can be successfully managed using the stepladder technique, including timely and appropriate interventions, claims a paper in the journal Ophthalmology.

Dr Paraaj Dave et al., L. V. Prasad Eye Institute, Hyderabad, India, reported the treatment outcomes in 28 eyes of 26 patients with malignant glaucoma between 1991 and 2009. The main outcome measures of the retrospective case series were IOP and central anterior chamber depth. Resolution was defined as eyes with an IOP of 21 mmHg or less and deepening of the central anterior chamber with or without topical anti-glaucoma medications.

The treatment algorithm consisted of anti-glaucoma medications and cycloplegics as first-line methods. The second-line therapies in pseudophakic eyes were laser hyaloidotomy and vitrectomy-hyaloidotomy-iridectomy (VHI) or transscleral cyclophotocoagulation (TSCPC).

Of the eyes studied, five were phakic and 23 were pseudophakic. Trabeculectomies were performed in 11 eyes, cataract surgery in 10 eyes and combined cataract and glaucoma surgery in 7 eyes.

The mean IOP decreased from 34±8.3 mmHg at presentation to 14.3±5.2 mmHg at the last follow up visit. Resolution of malignant glaucoma was seen in 27 eyes with 17 eyes resolved with one intervention and 10 eyes undergoing repeat procedures.

Medical treatment was advantageous in phakic eyes, laser hyaloidotomy was successful in pseudophakic eyes and vitrectomy and TSCPC was beneficial in refractory cases. The stepladder technique was successful in 96% of patients in the case series.

To read the abstract please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.